Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level-Reference-Cited by-同舟云学术

Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level

Published:2004-01 Issue:1 Volume:18 Page:45-49
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

Viard Jean-Paul,Burgard Marianne,Hubert Jean-Baptiste,Aaron Laurent,Rabian Cécile,Pertuiset Nathalie,Lourenço Maria,Rothschild Chantal,Rouzioux Christine

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference13 articles.

1. The Challenge of Viral Reservoirs in HIV-1 Infection

2. Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

3. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy

4. Decay of HIV-1 DNA in Patients Receiving Suppressive Antiretroviral Therapy

5. HIV RNA and HIV DNA in Peripheral Blood Mononuclear Cells Are Consistent Markers for Estimating Viral Load in Patients Undergoing Long-Term Potent Treatment

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size;JCI Insight;2024-07-09

2. The Prevalence of Overweight/Obesity and Related Comorbidities among HIV-Positive and HIV-Negative Patients Attending the Same Clinics in Gaborone, Botswana;Advances in Infectious Diseases;2024

3. Raltegravir Plus Nucleoside Reverse-Transcriptase Inhibitor (NRTI) Plus Lopinavir, NRTIs Plus Lopinavir for Second-Line Treatment of HIV: 96-Week Follow-up Results from a Randomized Controlled Trial;J BIOL REG HOMEOS AG;2023

4. A role for CD4+ helper cells in HIV control and progression;AIDS;2022-06-22

5. Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment;Frontiers in Immunology;2022-04-26